849674-12-0

Basic information

• Product Name: Ethanimidic acid, 2,2,2-trichloro-, (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ester
• CAS NO: 849674-12-0
• Molecular Formula: C12H8Cl3F6NO
• Molecular Weight: 402.551
• Mol File: 849674-12-0.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: Ethanimidic acid, 2,2,2-trichloro-, (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanimidic acid, 2,2,2-trichloro-, (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ester(849674-12-0)
• EPA Substance Registry System: Ethanimidic acid, 2,2,2-trichloro-, (1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ester(849674-12-0)

Safety Data

• Hazardous Substances Data: 849674-12-0(Hazardous Substances Data)

Upstream product

• 225920-05-8 (S)-3,5-bis(trifluoromethyl)-1-phenylethanol 
• 545-06-2 trichloroacetonitrile 

Downstream Products

• 920025-45-2 C₃₀H₃₇F₇O₇S₂ 
• 920025-46-3 C₃₀H₃₇F₇O₇S₂ 
• 545-06-2 trichloroacetonitrile 
• 1021817-09-3 C₂₃H₃₇FO₉S₃ 
• 594-65-0 trichloroacetamide 
• 349-59-7 3,5-bis(trifluoromethyl)styrene 
• 68120-60-5 1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-ol 
• 889126-30-1 tert-butyl (3S,4S)-4-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)piperidine-1-carboxylate 
• 860642-65-5 diethyl (1S,2S,3R,4S)-4-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)cyclohexane-1,2-dicarboxylate 
• 894790-87-5 (3R,4S)-4-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-cyclohexanone 
• 912807-36-4 (R)-1-[(1R,2R,3S)-3-{(R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy}-2-(4-fluorophenyl)cyclopentylmethyl]piperidine-3-carboxylic acid tert-butyl ester 
• 190266-45-6 [(1R,2R,3S)-3-{(R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy}-2-(4-fluorophenyl)cyclopentyl]methanol 

Relevant articles and documents

Asymmetric Synthesis of Merck's Potent hNK1Antagonist and Its Stereoisomers via Tandem Acylation/[3,3]-Rearrangement of 1,2-Oxazine N-Oxides

An asymmetric total synthesis of Merck's hNK1 antagonist and three of its stereoisomers was accomplished in 10 steps. The synthesis involves a stereoselective assembly of 1,2-oxazine N-oxide by the [4 + 2]-cycloaddition, site-selective C-H oxygenation usi

Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonists

3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy} -4-(4-fluorophenyl)octahydro-2H-isoindol-2-yl]-cyclopent-2-en-1-one (17) is a high affinity, brain-penetrant, hydroisoindoline-based neurokinin-1 (NK1) receptor antagonist with a long ce

Process for making hydroisoindoline tachykinin receptor antagonists

The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.